Target intelligence / Profile preview

Macrophage activation and immunometabolism

Molecular classification
Other
01

Overview

Macrophage activation and immunometabolism refers to the intrinsic link between a macrophage's metabolic state and its functional phenotype (O'Neill et al., 2016). Upon activation, macrophages undergo metabolic reprogramming to meet the energetic and biosynthetic demands of their specific immune roles (Kelly & O'Neill, 2015). Pro-inflammatory (M1-like) macrophages generally shift toward aerobic glycolysis and a truncated tricarboxylic acid (TCA) cycle, leading to the accumulation of metabolites like succinate and itaconate that further signal inflammatory responses (Mills et al., 2016). Conversely, anti-inflammatory (M2-like) macrophages rely more heavily on oxidative phosphorylation and fatty acid oxidation to support tissue repair and resolution of inflammation (Geeraerts et al., 2017). Dysregulation of these metabolic programs is a hallmark of many diseases, including cancer, where the tumor microenvironment can polarize macrophages to an immunosuppressive state, and atherosclerosis, where metabolic stress drives chronic inflammation (Viola et al., 2019). While not a single molecular target, the pathways governing macrophage immunometabolism are being explored for therapeutic intervention to re-polarize immune cells in various disease contexts.

Other names
Macrophage polarizationMetabolic reprogramming of macrophagesMyeloid immunometabolism
02

Mechanism of action

Modulation of intracellular metabolic pathways, such as glycolysis and the tricarboxylic acid cycle, to shift macrophage functional phenotypes between pro-inflammatory and anti-inflammatory states.

03

Biological functions

Immune responseMetabolic regulationInflammationPhagocytosisTissue repair
04

Disease associations

CancerAtherosclerosisType 2 diabetesRheumatoid arthritisObesity
05

Safety considerations

Systemic metabolic disruptionPotential for broad immunosuppressionOff-target effects in non-immune cellsImpaired tissue healing
06

Interacting drugs

Metformin

3 more in the full profile.

07

Biomarkers

LactateSuccinateItaconateCD80CD206Arginase-1

Beyond the preview

Go deeper on Macrophage activation and immunometabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage activation and immunometabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call